RxDoctor Payments Data

Sarah Adams

Medical · Petoskey, MINPI 1568559383

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,999 of the $11,714 with a category attached, or 85.4%. It is spread thinly across 41 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,714in general payments, 2019–2025

Across 496 payments — averaging $23.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Inspire Medical Systems, Inc.$2K
  • GSK$1K
  • Regeneron Healthcare Solutions, Inc.$859
  • Sanofi$679
  • Jazz Pharmaceuticals Inc.$613
  • plus $4K from 35 others

What the payments were for

  • Travel & lodging$1,0219%
  • Food & beverage$9,99985%
  • Education$6946%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,714 in reported general payments places this provider in the 95th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter398$340,647
Breztri AerosphereBudesonide/Glycopyr/Formoterol123$90,904
Advair HfaFluticasone Propion/Salmeterol71$35,473
Breo ElliptaFluticasone/Vilanterol52$28,147
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr27$26,237
Spiriva RespimatTiotropium Bromide34$24,469
Stiolto RespimatTiotropium Br/Olodaterol Hcl22$18,226
BelsomraSuvorexant33$14,799
SymbicortBudesonide/Formoterol Fumarate45$13,742
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate36$12,765
Albuterol Sulfate HfaAlbuterol Sulfate258$9,714
DuleraMometasone/Formoterol29$9,557
Fluticasone-SalmeterolFluticasone Propion/Salmeterol38$8,374
BreynaBudesonide/Formoterol Fumarate27$6,997
Roflumilast51$6,906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$1,426$395,031477 claims
AstraZenecaBreztri Aerosphere, Symbicort$2,319$104,646168 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat$451$47,77367 claims
MerckBelsomra, Dulera$138$24,35662 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$12$3,37314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 755 medical providers in Michigan.

Other medical in Petoskey

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →